Portal de Periódicos da CAPES

Autism-specific maternal autoantibodies recognize critical proteins in developing brain

2013; Springer Nature; Volume: 3; Issue: 7 Linguagem: Inglês

10.1038/tp.2013.50

2158-3188

Daniel Braunschweig, Paula Krakowiak, Paul Duncanson, Robert Boyce, R. Hansen, Paul Ashwood, Irva Hertz‐Picciotto, Isaac N. Pessah, Judy Van de Water,

Autism Spectrum Disorder Research

Autism spectrum disorders (ASDs) are neurodevelopmental in origin, affecting an estimated 1 in 88 children in the United States. We previously described ASD-specific maternal autoantibodies that recognize fetal brain antigens. Herein, we demonstrate that lactate dehydrogenase A and B (LDH), cypin, stress-induced phosphoprotein 1 (STIP1), collapsin response mediator proteins 1 and 2 (CRMP1, CRMP2) and Y-box-binding protein to comprise the seven primary antigens of maternal autoantibody-related (MAR) autism. Exclusive reactivity to specific antigen combinations was noted in 23% of mothers of ASD children and only 1% of controls. ASD children from mothers with specific reactivity to LDH, STIP1 and CRMP1 and/or cypin (7% vs 0% in controls; P<0.0002; odds ratios of 24.2 (95% confidence interval: 1.45-405)) had elevated stereotypical behaviors compared with ASD children from mothers lacking these antibodies. We describe the first panel of clinically significant biomarkers with over 99% specificity for autism risk thereby advancing our understanding of the etiologic mechanisms and therapeutic possibilities for MAR autism.